General - Vascular Access
Payments companies reported to CMS as associated with General - Vascular Access. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Vascular Access, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Vascular Access
These are the largest totals companies reported as associated with General - Vascular Access. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Pratik Sandesara | Atlanta, GA | Interventional Cardiology | $71,961.12 |
| Hayder Hashim | Washington, DC | Cardiovascular Disease | $70,070.01 |
| Saroj Neupane | Detroit, MI | Internal Medicine | $55,071.75 |
| William Nicholson | Atlanta, GA | Interventional Cardiology | $48,808.11 |
| Srinivasa Potluri | Plano, TX | Interventional Cardiology | $48,337.88 |
| Brian Jefferson | Nashville, TN | Interventional Cardiology | $47,417.87 |
| Ajay Kirtane | New York, NY | Interventional Cardiology | $42,352.34 |
| Gary Mintz | Washington, DC | $35,990.18 | |
| Evan Shlofmitz | Roslyn, NY | Interventional Cardiology | $34,054.69 |
| Ziad Ali | New York, NY | Internal Medicine | $32,368.93 |
Prescribed General - Vascular Access?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.